---
document_datetime: 2024-08-29 13:32:31
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/iasibon-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: iasibon-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.7937552
conversion_datetime: 2025-12-23 03:13:27.432268
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Iasibon

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| II/0025              | B.I.z - Quality change - Active substance - Other variation                                      | 01/02/2024                          | n/a                                         |                                  |           |
| N/0024               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 03/10/2022                          |                                             | PL                               |           |
| IA/0023/G            | This was an application for a group of variations.                                               | 11/07/2022                          | n/a                                         |                                  |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|         | the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method   |            |            |                        | B.I.b.1.c - Change in   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------|
| N/0022  | Minor change in labelling or package leaflet not the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                       | 10/01/2022 |            | PL                     | connected with          |
| IB/0021 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                            | 17/11/2020 | 12/11/2021 | SmPC, Labelling and PL |                         |
| N/0020  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                        | 03/04/2019 | 12/11/2021 | PL                     |                         |
| N/0019  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                        | 28/06/2018 | 12/11/2021 | PL                     |                         |
| N/0018  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                        | 18/10/2016 | 14/11/2016 | PL                     |                         |
| N/0017  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                        | 21/07/2016 | 14/11/2016 | PL                     |                         |

<div style=\"page-break-after: always\"></div>

| IAIN/0016   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                         | 26/11/2015   | 14/11/2016   | SmPC and PL           |                                                                                                                                                                                                                                                                                                                                                                                       |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0015      | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                | 23/07/2015   | 30/09/2015   | SmPC and PL           | Based on the review of the available information the CHMP is of the opinion that the quality, the safety and the efficacy of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considers that the benefit/risk profile of Iasibon remains favourable. The CHMP is of the opinion that the renewal can be granted with unlimited validity. |
| IA/0014     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                          | 11/05/2015   | n/a          |                       |                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0012/G   | This was an application for a group of variations. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) | 08/08/2014   | 08/07/2015   | SmPC                  |                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0013     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                           | 28/07/2014   | 08/07/2015   | SmPC, Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                       |
| N/0011      | Minor change in labelling or package leaflet not                                                                                                                                                                                                                                                                                       | 07/04/2014   | 22/05/2014   | PL                    |                                                                                                                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|           | connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                |            |            |                                  |                      |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------|
| IAIN/0010 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the                                                                                              | 16/10/2013 | n/a        |                                  | PSMF location        |
| II/0007   | To add a new manufacturer of the active substance. B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a new manufacturer of the AS that is                                   | 27/06/2013 | n/a        |                                  | supported by an ASMF |
| IB/0009   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 27/05/2013 | 22/05/2014 | SmPC, Annex II, Labelling and PL |                      |
| N/0008    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                               | 28/02/2013 | 22/05/2014 | PL                               |                      |
| IB/0006   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                         | 07/11/2012 | n/a        |                                  |                      |
| N/0005    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                               | 18/05/2012 | 04/07/2012 | PL                               |                      |
| N/0004    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                               | 08/02/2012 | 04/07/2012 | PL                               |                      |

<div style=\"page-break-after: always\"></div>

| IB/0002/G   | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO   | 14/12/2011   | 04/07/2012   | SmPC, Annex II, Labelling and PL   | new additional   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|------------------|
| IAIN/0003/G | This was an application for a group of variations. C.I.9.i - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) to a DDPS following the assessment of the same DDPS in relation to another medicinal product of the same                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 08/12/2011   | n/a          |                                    | MAH              |